Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

And compared to pre-IRA levels, new small-molecule cancer drug development programs fell over 40 percent last year. President Trump's order calls for correcting this imbalance. The Republican-backed ...

To better understand the health needs being addressed through online consultations, for reference, Doctor Anywhere’s 2024 data highlight the top five most in-demand specialties: dermatology, ear, nose ...

Scientists have created tiny disk-shaped particles that can swim on their own when hit with light, akin to microscopic robots that move through a special liquid without any external motors or ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare costs. Lifestyle changes and improved diets are critical but often ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary promise in the bout against obesity, helping patients lose an average of ...

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss.

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of clear differentiation” for rezpegaldesleukin in the atopic dermatitis space.

Nektar Therapeutics’ biologic drug rezpegaldesleukin takes a new approach to atopic dermatitis, or eczema, stimulating proliferation of immune cells that tamp down excessive immune responses ...

Nektar Therapeutics said on Tuesday its lead drug candidate met the main goal of a mid-stage study testing the drug in eczema patients, sending its shares up by nearly 140%.